The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

9 May 2016 16:00

RNS Number : 6950X
Judges Scientific PLC
09 May 2016
 

Press Release

9 May 2016

 

Judges Scientific plc

 

("Judges Scientific", "Judges", the "Company" or the "Group")

 

Director/PDMR Shareholding

 

Judges Scientific, a group involved in the buy and build of scientific instrument businesses, has today been advised that purchases of ordinary shares of 5p each in the Company ("Ordinary Shares") were made on 5 May 2016 by the Trustees of the Share Incentive Plan on behalf of three Directors of the Company, as follows:

 

A total of 16 Ordinary Shares were purchased on behalf of David Cicurel, the Chief Executive Officer of the Company. His resulting interest in the Company is 916,725 Ordinary shares representing 15.02 per cent of the issued Ordinary Share capital. In addition, he holds options over 9,275 Ordinary Shares under the Company's Share Option Plans.

 

A total of 16 Ordinary shares were purchased on behalf of Brad Ormsby, the Group Finance Director of the Company. His resulting interest in the Company is 150 Ordinary Shares representing nil per cent of the issued Ordinary Share capital. In addition, he holds options over 60,000 Ordinary Shares under the Company's Share Option Plans.

 

A total of 133 Ordinary shares were purchased on behalf of David Barnbrook, the Chief Operating Officer of the Company. His resulting interest in the Company is 19,836 Ordinary Shares representing 0.33 per cent of the issued Ordinary Share capital. In addition, he holds options over 28,325 Ordinary Shares under the Company's Share Option Plans.

 

The purchases by the Trustees were made at a price of 1,802.4p per Ordinary Share. Purchases of a further 852 Ordinary Shares were made on the same date and at the same price on behalf of 81 other members of staff under the Company's Share Incentive Plan.

 

-Ends-

 

For further information please contact:

 

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 203 829 6970

 

Shore Capital (Nominated Adviser & Broker)

 

Stephane Auton

Edward Mansfield

Tel: +44 (0) 20 7408 4090

Media enquiries:

Abchurch (Financial Public Relations)

 

Julian Bosdet

Canace Wong

Nessyah Hart

Tel: +44 (0) 20 7398 7714

www.abchurch-group.com

 

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 14 businesses acquired since it was first admitted to AIM in 2003.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.

 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

 

The Group's companies predominantly operate in niche end markets, with long term growth fundamentals and resilient margins.

 

For further information, please visit www.judges.uk.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBSGDULUGBGLC

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.